Roche’s Bet On Next-Gen Sequencing Poses New Challenge For Illumina’s Market Dominance
With Sequencing By Expansion Technology A Year Away From Commercial Launch, Competition Takes Note As Of Now
Roche’s new system is expected to be aggressively priced to undercut existing NGS providers (Shutterstock) 
